Crossmark

ASO Visual Abstract: Comparing Survival Differences Between Patients Undergoing Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early Stage Breast Cancer

Crossref DOI link: https://doi.org/10.1245/s10434-025-18217-5

Published Online: 2025-08-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yi, Min

Chavez-MacGregor, Mariana

Smith, Benjamin D.

Mitchell, Melissa P.

Caudle, Abigail S.

DeSnyder MD, Sarah M.

Kuerer, Henry M.

Hunt, Kelly K.
License Information

Text and Data Mining valid from 2025-08-27

Version of Record valid from 2025-08-27
More Information

Article History

First Online: 27 August 2025

Disclosures

: Support provided through a Cancer Center Support Grant (CA16672, PI: P. Pisters, MD Anderson Cancer Center), from the National Cancer Institute, National Institutes of Health. K.K.H. reports being on the medical advisory board of ArmadaHealth, AstraZeneca, and Daiichi Sankyo, as well as research funding to MD Anderson Cancer Center from Cairn Surgical, Eli Lilly & Co., and Lumicell. B.S. declares the following relationships, not related to the submitted work: research funding from Artidis and royalty and equity interest in Oncora Medical.

Document is current

Any future updates will be listed below